Gene · 7226
Papers2,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolution in metazoans of the TRPM channel family involves multiple gains and losses of genes and domains. | Mol Biol Evol | 2026 | 41968578 | PubTator, text mining | PubMed |
| Domain-Specific Agonist Binding Affinities Explain Structural and Functional Regulation of TRPM2. | bioRxiv | 2026 | 41959445 | PubTator, text mining | PubMed |
| Selenium protects granulosa cells from 3-nitropropionic acid-induced oxidative toxicity by regulating TRPM2-induced cell death. | Reprod Toxicol | 2026 | 41912122 | PubTator, text mining | PubMed |
| LDHA protects vascular endothelial cells from oxidative stress‑induced mitochondrial damage via HIF‑1α activation and glycolytic reprogramming. | Mol Med Rep | 2026 | 41891951 | PubTator, text mining | PubMed |
| TRPtracker: a community database for monitoring praziquantel sensitivity at TRPMPZQ variants. | Int J Parasitol Drugs Drug Resist | 2026 | 41865684 | PubTator, text mining | PubMed |
| Synergistic disruption of the blood-brain barrier in tree shrews by Methamphetamine and HIV-1 Tat via TRPM2-Mediated astrocyte inflammation. | Brain Behav Immun | 2026 | 41839355 | PubTator, text mining | PubMed |
| Exosomal cannabidiol: A promising candidate for targeted oral delivery against breast cancer. | Cancer Lett | 2026 | 41812824 | PubTator, text mining | PubMed |
| From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology. | Front Med (Lausanne) | 2026 | 41797792 | PubTator, text mining | PubMed |
| TREM2 and microglial immunity in Alzheimer's disease: mechanisms, genetics, and therapeutic opportunities. | Front Immunol | 2026 | 41789102 | PubTator, text mining | PubMed |
| Copper Homeostasis and Cuproptosis in Neurological Disorders. | Drug Des Devel Ther | 2026 | 41783572 | PubTator, text mining | PubMed |
| Pollution-Induced Allergy Skews Metabolism Toward Obesity-A Conceptual Review. | Curr Issues Mol Biol | 2026 | 41751460 | PubTator, text mining | PubMed |
| Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | 41737608 | PubTator, text mining | PubMed |
| Recent Progress in Selenium Nanomedicines for Ocular Diseases. | Int J Nanomedicine | 2026 | 41737035 | PubTator, text mining | PubMed |
| Progress in the study of ion channel function, mechanisms, and mathematical modeling in Parkinson's disease. | iScience | 2026 | 41732483 | PubTator, text mining | PubMed |
| Targeting pyroptosis in periodontitis: mechanisms and therapeutic strategies. | Front Immunol | 2026 | 41727505 | PubTator, text mining | PubMed |
| Pulpitis as a microbial disease: single-cell insights into host responses and diagnostic biomarkers for vital pulp therapy. | J Oral Microbiol | 2026 | 41717505 | PubTator, text mining | PubMed |
| TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin's Antitumor Action in Laryngeal Carcinoma Cells. | Int J Mol Sci | 2026 | 41683568 | PubTator, text mining | PubMed |
| Transient signaling of free ADP-ribose monitored with an intracellular biosensor. | bioRxiv | 2026 | 41676587 | PubTator, text mining | PubMed |
Selenium Nanoparticles Protect Retinal Pigment Epithelial Cells Against Experimental Age-Related Macular Degeneration-Induced Mitochondrial Oxidative Toxicity and Apoptosis Through the Modulation of the TRPM2 Channel. | J Biochem Mol Toxicol | 2026 | 41665215 | PubTator, text mining | PubMed |
| Pathophysiological significance of the TRPM2 ion channel as a potential target in cancer, neurological disorders, and ischemia/reperfusion injury. | Pharmacol Res | 2026 | 41655822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7226/papers?page=2